|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.248 SEK | +2.13% |
|
-0.79% | -36.65% |
| 05-06 | IRLAB Q1 operating result swings to profit of SEK 10.7 mln | RE |
| 05-06 | Irlab reports growth in revenue and operating profit | FW |
Executive Committee: IRLAB Therapeutics AB
| Manager | Positions heldSince | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Kristina Torfgård 63 year |
| ||||||||
Nicholas Waters 64 year |
| ||||||||
Clas Sonesson 65 year |
| ||||||||
Joakim Tedroff 65 year |
| ||||||||
Peder Svensson 64 year |
| ||||||||
Gustaf Albért 58 year |
|
Composition of the Board of Directors: IRLAB Therapeutics AB
| Director | CommitteesSince | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Carola Elisabet Lemne 68 year |
| ||||||||
Rein Piir 68 year |
| ||||||||
Gunnar Olof Olsson 73 year |
| ||||||||
Christer Nordstedt 64 year |
| ||||||||
Veronica Wallin 40 year |
|
Latest Appointments: IRLAB Therapeutics AB
Former Officers and Directors: IRLAB Therapeutics AB
| Insider | Positions held SinceUntil | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
| ||||||||||
|
Age distribution of managers
Parity Men Women
| Male | 11 |
|---|---|
| Female | 1 |
Of which Executive Committee
| Male | 6 |
|---|---|
| Female | 0 |
Of which Directors
| Male | 4 |
|---|---|
| Female | 1 |
Departures of Key Persons
Chief Executive Officer
30/06/2022 19/02/2023
Chairman
31/12/2015 19/02/2023
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















